Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

The document explains various skin conditions and their treatments.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Hyperthyroidism can hide signs of high androgen levels in females.

Most women with excessive hair growth have a hormonal cause.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Testosterone may slow down wound healing and increase inflammation.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Birth control pills can help reduce mild to moderate acne in women.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Severe acne in a young girl may indicate underlying hormonal issues.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Removing Lrig1-positive stem cells in mice causes temporary loss of sebaceous glands.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Androgens can both increase and decrease hair growth in different parts of the body.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.